Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Dunlop E, Ferguson A, Mueller T, Baillie K, Laskey J, Clarke J, Kurdi A, Wales A, Connolly T, Bennie M
Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study
Involving patients and clinicians in the design of wireframes for cancer medicines electronic patient reported outcome measures (ePROMs) in clinical care: a mixed methods study
Emma Dunlop;
Aimee Ferguson;
Tanja Mueller;
Kelly Baillie;
Jennifer Laskey;
Julie Clarke;
Amanj Kurdi;
Ann Wales;
Thomas Connolly;
Marion Bennie
ABSTRACT
Background:
The cancer medicines landscape is rapidly evolving. Electronic Patient Reported Outcome Measures (ePROMs) can help identify patients’ supportive care needs relating to treatment.
Objective:
This study aims to establish what could constitute a useful and easy to use patient app and clinician dashboard for cancer medicines ePROMs in routine cancer care, and understand intention to use these technologies.
Methods:
A two stage, mixed methods approach was adopted: interviews and focus groups with cancer clinicians and patients to test wireframes (i.e. mock-ups) of a clinician dashboard and a patient app for face validity (Stage 1); and based on refinements, validate the improved wireframes through online questionnaires (Stage 2).
Results:
14 clinicians and 19 patients participated in Stage 1 interviews/focus groups. All agreed the app/dashboard looked easy to use and that they would intend to use it (if available). Clinicians had concerns around integrating the dashboard into existing care records. In Stage 2, eight clinicians and 16 patients completed online questionnaires. All reported a relatively high perceived ease of use, usefulness and intention to use each technology. Although clinicians felt viewing patient reported outcome measures (PROMs) via the dashboard would have little influence on their treatment decision making, they would still use the dashboard.
Conclusions:
This study explores the perceived ease of use, usefulness and intention to use ePROMs solutions in cancer services in Scotland. Patients and clinicians stated they would find such technologies easy to use, useful and would intend to use them routinely if available. Some differences were identified between the two stages, which warrant further research.
Citation
Please cite as:
Dunlop E, Ferguson A, Mueller T, Baillie K, Laskey J, Clarke J, Kurdi A, Wales A, Connolly T, Bennie M
Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study